Literature DB >> 11181168

At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules.

J W Yewdell1, U Schubert, J R Bennink.   

Abstract

CD8(+) T cells are a critical element of vertebrate immune responses to viruses and other intracellular parasites. They roam the body, monitoring cells for the presence of foreign peptides associated with MHC class I molecules of the major histocompatibility complex (MHC). Although it is clear that most of these peptides are generated through the action of proteasomes, the nature of the substrates degraded by proteasomes is an open question. Recent findings indicate that the major pool of substrates consists of a heterogeneous subset of proteins that are degraded within minutes of their synthesis. Evidence suggests that the fraction of newly synthesized proteins targeted for destruction is remarkably high - 30% or more, depending on cell type - possibly because they are defective in some way and cannot reach their intended conformation or location cellular in a time frame deemed appropriate by cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181168     DOI: 10.1242/jcs.114.5.845

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  24 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

2.  Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.

Authors:  Judy Tellam; Corey Smith; Michael Rist; Natasha Webb; Leanne Cooper; Tony Vuocolo; Geoff Connolly; David C Tscharke; Michael P Devoy; Rajiv Khanna
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

3.  Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins.

Authors:  Kalavathi Dasuri; Philip J Ebenezer; Le Zhang; Sun Ok Fernandez-Kim; Romina M Uranga; Elena Gavilán; Alessia Di Blasio; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2010-08-01       Impact factor: 7.376

Review 4.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

5.  The nature and extent of contributions by defective ribosome products to the HLA peptidome.

Authors:  Dmitry Bourdetsky; Christian E H Schmelzer; Arie Admon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-08       Impact factor: 11.205

Review 6.  The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity.

Authors:  Christopher V Nicchitta; Deanna M Carrick; Julie C Baker-Lepain
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

Review 7.  Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol.

Authors:  Melanie Fassbender; Sylvia Herter; Rafaela Holtappels; Hansjörg Schild
Journal:  Med Microbiol Immunol       Date:  2008-03-14       Impact factor: 3.402

8.  Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.

Authors:  Jiayu Gao; Judy M Coulson; Adrian Whitehouse; Neil Blake
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

Review 9.  Antigen processing and presentation in HIV infection.

Authors:  Julie Boucau; Sylvie Le Gall
Journal:  Mol Immunol       Date:  2018-04-07       Impact factor: 4.407

10.  The yeast PNC1 longevity gene is up-regulated by mRNA mistranslation.

Authors:  Raquel M Silva; Iven C N Duarte; João A Paredes; Tatiana Lima-Costa; Michel Perrot; Hélian Boucherie; Brian J Goodfellow; Ana C Gomes; Denisa D Mateus; Gabriela R Moura; Manuel A S Santos
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.